Showing results (431-440 of 636) with videos related to

Sort By:
Pageof 64
Policy Brief (UCLA Center for Health Policy Research)|October 9, 2004
Asthma among California's children, adults and the elderly: a geographic look by legislative districtsCarolyn A Mendez-Luck, Hongjian Yu, Ying-Ying Meng, et al.
Oecologia|January 27, 2007
Maternal investment in reproduction and its consequences in leatherback turtlesBryan P Wallace, Paul R Sotherland, Pilar Santidrian Tomillo, et al.
American Journal of Physiology. Renal Physiology|August 20, 2010
Polycystic kidney disease in Han:SPRD Cy rats is associated with elevated expression and mislocalization of SamCystinShizuko Nagao, Miwa Morita, Masanori Kugita, et al.
Plos One|September 7, 2013
The role of phospholipase D in modulating the MTOR signaling pathway in polycystic kidney diseaseYang Liu, Andres Käch, Urs Ziegler, et al.
Physics in Medicine and Biology|August 4, 2010
Accuracy and resolution of THz reflection spectroscopy for medical imagingCaroline B Reid, Emma Pickwell-MacPherson, Jan G Laufer, et al.
Experimental Cell Research|April 8, 2017
Ouabain promotes partial epithelial to mesenchymal transition (EMT) changes in human autosomal dominant polycystic kidney disease (ADPKD) cellsJessica Venugopal, Jeffrey McDermott, Gladis Sanchez, et al.
Cell Death & Disease|October 15, 2021
The tyrosine-kinase inhibitor Nintedanib ameliorates autosomal-dominant polycystic kidney diseaseAbeda Jamadar, Sreenath M Suma, Sijo Mathew, et al.
Lancet (London, England)|June 22, 2002
Joint teleconsultations (virtual outreach) versus standard outpatient appointments for patients referred by their general practitioner for a specialist opinion: a randomised trialP Wallace, A Haines, R Harrison, et al.
American Journal of Physiology. Renal Physiology|June 24, 2011
Ouabain activates the Na-K-ATPase signalosome to induce autosomal dominant polycystic kidney disease cell proliferationAnh-Nguyet T Nguyen, Kyle Jansson, Gladis Sánchez, et al.
Trials|April 25, 2015
Personalized versus standardized dosing strategies for the treatment of childhood amblyopia: study protocol for a randomized controlled trialMerrick J Moseley, Michael P Wallace, David A Stephens, et al.
Pageof 64